Mark R Rigby, MD, PhD

Trials

Studies that name Mark R Rigby, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:54 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT01116752 · Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial

  Indiana University · completed · Pediatric Patient (1m-21y), ICU Admission, Hyperglycemia · principal investigator
• N/A
  NCT01116674 · Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry

  Indiana University · completed · Hypoglycemia Hyperglycemia · principal investigator
• Ph2
  NCT00965458 · Inducing Remission in Type 1 Diabetes With Alefacept

  National Institute of Allergy and Infectious Diseases (NIAID) · terminated · New-onset Type 1 Diabetes Mellitus · principal investigator
• Ph2
  NCT00737763 · Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab

  Emory University · withdrawn · Diabetes Mellitus, Type 1 · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Multicenter Trial to Control Hyperglycemia in Pediatric Critical Care
  R21DK081847 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Mark Ransford Rigby · fiscal years 2010 to 2011
  Named on NCT01116674